Articles dans des revues avec comité de lecture (214)
  1. 144. Taildeman, J., Demetter, P., Rottiers, I., Holtappels, G., Bachert, C., Cuvelier, C., & Pérez-Novo, C. A. (2010). Identification of the nasal mucosa as a new target for leptin action. Histopathology, 56(6), 789-798. doi:10.1111/j.1365-2559.2010.03552.x
  2. 145. Van Damme, N., Deron, P., Van Roy, N., Demetter, P., Bols, A., Van Dorpe, J., Baert, F., Van Laethem, J.-L., Speleman, F., Pauwels, P., & Peeters, M. (2010). Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas. BMC cancer, 10, 189. doi:10.1186/1471-2407-10-189
  3. 146. Hoorens, A., Jouret-Mourin, A., Sempoux, C., Demetter, P., De Hertogh, G., & Teugels, E. (2010). Accurate KRAS mutation testing for EGFR-targeted therapy in colorectal cancer: emphasis on the key role and responsibility of pathologists. Acta gastro-enterologica Belgica (Ed. multilingue), 73(4), 497-503.
  4. 147. Hoorens, A., De Ridder, M., Jouret-Mourin, A., Sempoux, C., Cuvelier, C. A., Nagy, N., De Hertogh, G., Geboes, K., & Demetter, P. (2010). Pathologische beoordeling van het resectiepreparaat bij rectumkanker. Nederlands tijdschrift voor oncologie, 7, 135-145.
  5. 148. Vandenbroucke, K., de Haard, H., Beirnaert, E., Dreier, T., Lauwereys, M., Huyck, L., Van Huysse, J., Demetter, P., Steidler, L., Remaut, E., Cuvelier, C. A., & Rottiers, P. (2010). Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunology, 3(1), 49-56. doi:10.1038/mi.2009.116
  6. 149. Marechal, R., De Schutter, J., Nagy, N., Demetter, P., Lemmers, A., Devière, J., Salmon, I., Tejpar, S., & Van Laethem, J.-L. (2010). Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients. BMC cancer, 10, 340. doi:10.1186/1471-2407-10-340
  7. 150. Mathieu, A., Weynand, B., Verbeken, E., Da Silva, S., Decaestecker, C., Salmon, I., & Demetter, P. (2009). Comparison of four antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in non-small cell lung cancer. Lung cancer, 1301, 152-162. doi:10.1016/j.lungcan.2009.09.003
  8. 151. Arvanitakis, M., Hookey, L., Tessier, G., Demetter, P., Nagy, N., Stellke, A., De Maertelaer, V., Devière, J., & Le Moine, O. (2009). Intraductal optical coherence tomography during endoscopic retrograde cholangiopancreatography for investigation of biliary strictures. Endoscopy, 41(8), 696-701. doi:10.1055/s-0029-1214950
  9. 152. Casneuf, V. F., Demetter, P., Boterberg, T., Delrue, L., Peeters, M., & Van Damme, N. (2009). Antiangiogenic versus cytotoxic therapeutic approaches in a mouse model of pancreatic cancer: an experimental study with a multitarget tyrosine kinase inhibitor (sunitinib), gemcitabine and radiotherapy. Oncology Reports, 22(1), 105-113.
  10. 153. Lemmers, A., Gustot, T., Durnez, A., Evrard, S., Moreno, C., Quertinmont, E., Vercruysse, V., Demetter, P., Franchimont, D., Le Moine, O., Geerts, A., & Devière, J. (2009). An inhibitor of interleukin-6 trans-signalling, sgp130, contributes to impaired acute phase response in human chronic liver disease. Clinical and experimental immunology, 156(3), 518-527. doi:10.1111/j.1365-2249.2009.03916.x
  11. 154. Taildeman, J., Pérez-Novo, C. A., Rottiers, I., Ferdinande, L., Waeytens, A., De Colvenaer, V., Bachert, C., Demetter, P., Waelput, W., Braet, K., & Cuvelier, C. A. (2009). Human mast cells express leptin and leptin receptors. Histochemistry and cell biology, 131(6), 703-711. doi:10.1007/s00418-009-0575-3
  12. 155. Marechal, R., Demetter, P., Nagy, N., Berton, A., Decaestecker, C., Polus, M., Closset, J., Devière, J., Salmon, I., & Van Laethem, J.-L. (2009). High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. British Journal of Cancer, 100(9), 1444-1451. doi:10.1038/sj.bjc.6605020
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Suivant >>